20多年后的塔维
Adriana Postolache1, Simona Sperlongano2, Patrizio Lancellotti1
1Cardiology Department, GIGA Cardiovascular Sciences, University of Liège Hospital, CHU Sart Tilman, 4000 Liège, Belgium.
Journal of clinical medicine
|September 9, 2023
概括
通过导管的大动脉干预 (TAVI) 在过去20年里有了显著的进化,扩大了患者的资格并减少了并发症. 本综述涵盖了TAVI患者评估,程序变化以及当前的挑战.
科学领域:
- 心脏病学 心脏病学
- 干预心脏病学 干预心脏病学
- 医疗技术 医疗技术 医学技术
背景情况:
- 自20多年前开始实施以来,过导管大动脉干预 (TAVI) 已经取得了重大进展.
- 最初开发用于不可手术的患者,TAVI现在适用于更广泛的患者,包括那些手术风险较低的患者.
- 该技术已经证明,随着时间的推移,并发症率显著降低.
研究的目的:
- 提供跨导管大动脉干预 (TAVI) 的综合性审查.
- 讨论TAVI程序和患者选择标准的演变.
- 概述与TAVI相关的当前并发症和挑战.
主要方法:
- 对TAVI的现有文献和临床数据的审查.
- 分析TAVI的程序修改和技术进步.
- 检查TAVI.患者的治疗结果和并发症率.
主要成果:
- 塔维的应用范围已经从不可手术的扩展到患有大动脉狭窄症的低风险患者.
- 在TAVI技术的显著改进导致并发症发生率下降.
- 该审查详细介绍了患者评估,程序演变以及当前的TAVI挑战.
结论:
- 在治疗大动脉狭窄方面,TAVI代表了一项重大进步,提供了一种不那么侵入性的选择.
- 为了优化结果,TAVI技术和患者选择的持续发展至关重要.
- 解决当前的并发症和挑战将进一步加强TAVI在心血管保健中的作用.
相关概念视频
Aortic Regurgitation III: Medical Management
24
Aortic regurgitation (AR) is when the aortic valve does not close or seal properly, leading to backward blood circulation from the aorta into the left ventricle during diastole. Common causes of AR include rheumatic heart disease, congenital valve defects, and aortic root dilation. Managing AR requires a multifaceted approach to alleviate symptoms, preserve left ventricular function, and address the underlying cause of the regurgitation. Patients with symptomatic AR or significant left...
24
Mitral Stenosis I: Introduction
15
Mitral Valve Stenosis (MVS) is a heart condition where the mitral valve narrows, impeding blood circulation from the left atrium to the left ventricle. The etiology and pathophysiology of this condition are multifaceted, leading to a cascade of cardiovascular complications.Causes of Mitral Valve StenosisRheumatic Heart Disease: It is the main cause of mitral valve stenosis, particularly in developing nations. This condition arises from rheumatic fever, an inflammatory illness resulting from...
15
Mitral Stenosis III: Medical Management
12
Mitral stenosis, a condition marked by the narrowing of the mitral valve, necessitates an integrated approach for effective management. This approach includes preventative measures, medical therapy, and surgical interventions to reduce symptoms and prevent complications.PreventionPrevention of mitral stenosis primarily focuses on reducing the incidence of bacterial infections, particularly streptococcal infections, which can lead to rheumatic fever and subsequent valvular damage. Timely...
12
Mitral Valve Prolapse II: Assessment and Management
20
IntroductionA range of clinical features characterizes Mitral Valve Prolapse (MVP), but it is important to note that many individuals with MVP are asymptomatic and may remain so throughout their lives. For those who do exhibit symptoms, the following are the key clinical features:Palpitations: This is a common symptom where individuals feel an irregular or rapid heartbeat. Palpitations in MVP are often due to arrhythmias such as premature ventricular contractions or supraventricular...
20
Aortic Regurgitation I: Introduction
10
IntroductionAortic regurgitation is characterized by the backward flow of blood from the aorta into the left ventricle during diastole and arises from the improper closure of the aortic valve. This condition results in left ventricular volume overload and can stem from both acute and chronic etiologies, each contributing uniquely to the disease's progression and symptomatology.Acute and Chronic CausesAcute aortic regurgitation often results from events that suddenly impair the integrity of the...
10


